Disclosure Purpose
Regulatory intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. Ho/49/14/14(7)2025-CFD-POD2/1/3762/2026, last updated on January 30, 2026.
Board Meeting Details
The Board of Directors meeting was held on Wednesday, October 21, 2026, commencing at 5:30 PM and concluding at 6:30 PM.
Director Appointments
Executive Director Appointment
The Board approved the appointment of Mr. Swapan Mohit Goli (DIN: 12006048) as an Additional Director and Whole-time Director designated as "Executive Director" with effect from October 21, 2026, for a period of 5 years (until October 20, 2031), subject to approval of members of the Company.
Profile: Mr. Goli holds a Master of Science in Engineering Management from Trine University, Indiana, USA, and a Bachelor of Science in Electronics and Communication Engineering from Vellore Institute of Technology, Tamil Nadu. He has more than five years' experience in pharmaceutical manufacturing operations, business development, and compliance management. He has expertise in production optimization, resource utilization, and efficiency improvement.
Non-Executive Non-Independent Director Appointment
The Board approved the appointment of Mr. Mahendra Kumar (DIN: 12004279) as an Additional Director designated as "Non-Executive Non-Independent Director" with effect from October 21, 2026.
Profile: Mr. Mahendra Kumar is a qualified Company Secretary with knowledge of the Companies Act, 2013, SEBI regulations, and applicable regulatory requirements for listed entities. He is responsible for ensuring corporate and regulatory compliances, facilitating board and shareholders' meetings, maintaining statutory records, and coordinating with regulatory authorities and stock exchanges.
Independent Director Appointments
The Board approved the appointment of two Independent Directors:
1. Mr. Ankur Khedar (DIN: 11768298) as Additional Director designated as "Non-Executive Independent Director" with effect from October 21, 2026, for a period of 5 years (until October 20, 2031), subject to shareholder approval.
Profile: CA Ankur Khedar is a qualified Chartered Accountant and partner at YKG Corp, a Delhi-based firm. His areas of professional expertise include audits, advisory, litigation, export incentives, and financial due diligence.
2. Ms. Pravita Khandelwal (DIN: 10831291) as Additional Director designated as "Non-Executive Independent Director" with effect from October 21, 2026, for a period of 5 years (until October 20, 2031), subject to shareholder approval.
Profile: Ms. Pravita Khandelwal is a qualified Company Secretary with over 9 years of experience in corporate law, taxation, corporate governance, and statutory regulatory compliance. She holds a Bachelor of Laws (LL.B.), Master of Commerce (M.Com.), and Company Secretary qualification from the Institute of Company Secretaries of India (ICSI).
Compliance Disclosures
All four appointees are not debarred from holding the office of director by virtue of any order of SEBI or any other authority. There are no disclosed relationships between directors.